接受抗逆转录病毒治疗的HIV成人患者脂肪量进行性增加,但性别与解剖部位模式不同
研究纳入Modena HIV代谢门诊839名女性和1759名男性HIV感染者,每6-12个月行DXA扫描,中位随访4.6年。两性躯干和腿部脂肪均持续增加,男性年增幅高于女性;女性、每年ART使用(尤其TDF和INSTI)、BMI升高、无自报体力活动及CD4最低值<200 cells/mm3与脂肪量增加相关。
要点
- 接受ART的HIV成人躯干和腿部脂肪随随访持续增加,男性年增幅高于女性
- 女性、每年ART使用(尤其TDF和INSTI)、BMI升高、无体力活动及CD4最低值<200 cells/mm3与脂肪量增加相关
- 临床应关注ART期间脂肪分布变化,尤其女性及低CD4最低值者
核心结论
- 在接受ART的HIV感染者中,躯干和腿部脂肪量在中位4.6年随访期间持续增加,尤其女性;控制传统危险因素后,HIV和ART相关危险因素显现。
研究设计与样本
- Modena HIV代谢门诊的男性和女性HIV感染者每6-12个月接受DXA扫描,最长10年,中位4.6年。
- 839名女性和1759名男性贡献两次及以上DXA扫描。
- 基线中位年龄44岁,BMI 22.9 kg/m2,76%基线时ART下病毒学抑制。
主要发现
- 两性躯干和腿部脂肪在研究期间持续增加。
- 女性躯干和腿部脂肪年均增加分别为3.6%和7.5%,男性分别为6.3%和10.8%。
- 多因素分析中与更高脂肪量相关的因素包括女性、每年ART使用(尤其TDF和INSTI)、每单位BMI增加、无自报体力活动及CD4最低值<200 cells/mm3。
临床怎么用
- 对接受ART的HIV感染者应关注脂肪量进行性增加,尤其女性及CD4最低值<200 cells/mm3者。
- 使用TDF或INSTI方案及无体力活动者可能需加强体重和体脂监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Although weight gain on ART is common, the long-term trajectory of and factors affecting increases in fat mass in people living with HIV are not well described. METHODS: Men and women living with HIV in the Modena HIV Metabolic Clinic underwent DXA scans every 6-12 months for up to 10 years (median 4.6 years). Regression modelling in both combined and sex-stratified models determined changes in and clinical factors significantly associated with trunk and leg fat mass over the study period. RESULTS: A total of 839 women and 1759 men contributed two or more DXA scans. The baseline median age was 44 years and BMI 22.9 kg/m2; 76% were virologically suppressed on ART at baseline. For both sexes, trunk and leg fat consistently increased over the study period, with mean yearly trunk and leg fat gain of 3.6% and 7.5% in women and 6.3% and 10.8% in men, respectively. In multivariate analysis, factors associated with greater fat mass included female sex, per-year ART use (specifically tenofovir disoproxil fumarate and integrase strand transfer inhibitor therapy), per-unit BMI increase, no self-reported physical activity and CD4 nadir <200 cells/mm3. CONCLUSIONS: Among people living with HIV on ART, trunk and leg fat mass increased steadily over a median of 4.6 years of follow up, particularly among women. After controlling for traditional risk factors, HIV- and ART-specific risk factors emerged.
引用
- Debroy P, Sim M, Erlandson KM, et al. Progressive increases in fat mass occur in adults living with HIV on antiretroviral therapy, but patterns differ by sex and anatomic depot. J Antimicrob Chemother. 2019. PMID: 30668716. doi:10.1093/jac/dky551
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。